InvestorsObserver
×
News Home

Should You Accumulate Jasper Therapeutics Inc (JSPR) Stock Thursday?

Thursday, October 21, 2021 10:24 AM | InvestorsObserver Analysts

Mentioned in this article

Should You Accumulate Jasper Therapeutics Inc (JSPR) Stock Thursday?

Jasper Therapeutics Inc (JSPR) stock is higher by 42.62% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives JSPR stock a score of 68 out of a possible 100. That rank is primarily influenced by a long-term technical score of 97. JSPR's rank also includes a fundamental score of 55. In addition to the average rating from Wall Street analysts, JSPR stock has a mean target price of $21.00. This means analysts expect the stock to increase 49.79% over the next 12 months. The short-term technical score for JSPR is 50.

Overall Score - 68
JSPR has an Overall Score of 68. Find out what this means to you and get the rest of the rankings on JSPR!

What's Happening with JSPR Stock Today

Jasper Therapeutics Inc (JSPR) stock has fallen -1.27% while the S&P 500 is lower by -0.05% as of 10:22 AM on Thursday, Oct 21. JSPR is lower by -$0.18 from the previous closing price of $14.20 on volume of 279,304 shares. Over the past year the S&P 500 has gained 31.97% while JSPR is higher by 42.62%. JSPR lost -$0.34 per share in the over the last 12 months. Click Here to get the full Stock Report for Jasper Therapeutics Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App